Presentations

Webcast: Wall Street Analyst Forum Presentation
Date: 2/28/05 9:00AM EST		 

Fake blood passes early tests - A Costa Mesa-based company is developing Oxycyte, a synthetic blood for use in surgery.

Nonclinical Safety of Oxycyte-An Intravenous Perfluorocarbon Oxygen Carrier

Blood Pharmacokinetics of Oxycyte, a Perfluorocarbon-Based Intravenous Oxygen Carrier

Detemination of Gas Solubilities in Perfluorocarbons and Perfluorocarbon Emulsions Intended for Use as Blood Substitutes

Development and Properties of Oxycyte: A New Perfluorocarbon Blood Substitute

Effect of Perfluorocarbon (PFC) Blood Substitutes on Pulmonary Hyperinflation in Rabbits

Effect of Oxycyte Treatment on Permanent Focal Cerebral Ischemia in Rats

Comparison of Oxygen Carrying Capacity of a New Perfluorocarbon (PFC) Blood Substitute in Rats Breathing Room Air or 100% Oxygen